In the first year following diagnosis, we found increased cumulative incidence risk ratios in a number of outcomes including: - Any mental, behavioural, or neurodevelopmental disorder 1.96 (1.93 - 1.99) - Postpartum depression 2.70 (2.61 - 2.79) - Eating disorders 2.06 (1.85 - 2.89) - PTSD 1.77 (1.69 - 1.86) We also saw significantly increased risk in rare but serious outcomes such as: - Wernicke's encephalopathy 2.39 (1.25 - 4.56) - Puerperal psychosis 1.80 (1.48 - 2.20) Interestingly, cases of hyperemesis gravidarum with metabolic disturbance displayed a significantly lower risk of any depression and postpartum depression compared with those without metabolic disturbance
Injectable Semaglutide : Comes in various strengths, including 0.25 mg, 0.5 mg, 1 mg, and 2 mg pens, allowing for a gradual increase in dosage as needed
These medications are a class of drugs known as GLP-1 agonists because they mimic a hormone in our body called GLP-1 which regulates hunger, appetite, and cravings
Because the face has so little to spare, the change is visible early
Poor Dietary Quality Is Associated with Increased Inflammation in Swedish Patients with Rheumatoid Arthritis
Interested in learning more about losing weight
